dr. eytan stein on targeting mutations in acute myeloid leukemia
Published 8 years ago • 217 plays • Length 1:19Download video MP4
Download video MP3
Similar videos
-
1:08
dr. eytan stein on multiple targets in acute myeloid leukemia
-
1:02:03
personalized medicine for your acute myeloid leukemia | dr. eytan stein #aml
-
2:36
eha 2022 | eytan stein | tamibarotene and lanraplenib (lanra) updates for acute myeloid leukemia
-
1:11
dr. eytan stein on novel combinations in aml
-
1:25
therapeutic targeting of splicing factor mutations in myeloid malignancies
-
0:56
dr. eytan stein discusses the idh2 inhibitor ag-221 in aml
-
6:16
allogeneic stem cell transplant: kat's story
-
4:10
explore idh mutations
-
6:35
understanding aml
-
5:04
ash impact series: eytan stein, md - latest developments in targeted therapies for aml
-
2:39
how do gene mutations affect aml treatment choices?
-
2:57
targeting idh mutations for the treatment of aml
-
1:27
how do targeted treatments for idh1 and idh2 mutations work in acute myeloid leukemia (aml)?
-
1:17
dr. uy on therapy selection in acute myeloid leukemia
-
5:15
high-risk mds/aml: genomic-driven approaches from ash19 - eytan stein, md
-
7:43
what are current and emerging aml treatment approaches?
-
29:44
thriving with aml: what you should know about care and treatment
-
1:45
how to optimally manage relapse in aml
-
6:10
targeting idh1/2 in aml
-
1:37
a phase ii trial evaluating e7820 in patients with aml with splicing factor mutations
-
2:38
primary and secondary resistance in aml
-
7:09
aml on the go: targeted therapy of idh1/idh2 mutated aml